CTCF and Alzheimer disease: The epigenetic effects of this variant are likely mediated by the disruption of CTCF binding at one of two anchor sites of a repressive chromatin loop leading to increased MS4A6A expression and AD risk, although investigation of the mechanistic details of this model will require further experimentation.